Advanced Clinical-Based Technologies for Monitoring Physical Function in Breast Cancer Survivors: Scoping Review
ABSTRACT
Background:
Background:
Individuals surviving breast cancer often face long-term impairments in physical function, significantly impacting their quality of life. Conventional clinical assessments frequently lack the precision and real-time feedback necessary for comprehensive evaluation.
Objective:
Objective:
This scoping review aims to systematically explore and map the use of advanced clinical-based technologies for monitoring physical functions such as balance, strength, and range of motion (ROM) in breast cancer survivors, identifying current practices and literature gaps.
Methods:
Methods:
A comprehensive literature search was conducted across MEDLINE, Scopus, CINAHL, and Web of Science databases. Inclusion criteria focused on studies involving adults with breast cancer using advanced clinical-based technologies for monitoring physical function. Screening and selection followed PRISMA guidelines. Data extraction captured study characteristics, participant demographics, technologies used, and key findings.
Results:
Results:
The 17 included studies, involving 720 participants aged 30 to 75 years, demonstrated a growing interest in this field, with 11 studies published after 2017. Technologies spanned balance platforms (force plates, Sensory Organization Test, markerless motion capture), isokinetic dynamometry (Biodex systems), and motion capture or inclinometer–based ROM assessment (e.g., Kinect, digital inclinometers). Inclinometers dominated clinical ROM measurements, while markerless systems demonstrated promising reliability and portability. Biodex systems provide precise strength metrics but remain costly. Force plates and Sensory Organization Test dominated balance assessments.
Conclusions:
Conclusion: Advanced clinical–based technologies enhance objectivity and precision in assessing physical function among breast cancer survivors, yet standardization across tools is lacking. Standardizing these tools and methodologies is essential for broader clinical adoption. Future research should prioritize consensus-building and longitudinal applications to facilitate routine clinical integration and optimize survivorship care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.